Get notified when RXRX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: RXRX RECURSION PHARMACEUTICALS, INC. 8-K

Recursion founder Chris Gibson to step down from Board in June 2026

Filed April 30, 2026 · Period ending April 28, 2026 · ~1 min read

Key Changes

  • medium

    Founder and Board Chair Chris Gibson will not seek re-election when his term expires at the June 2026 annual meeting, transitioning to a strategic advisor role.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • low

    Gibson's departure is not due to any disagreement with the company on operations, policies, or practices; he will remain Chair through the annual meeting.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • low

    CEO Najat Khan confirmed Gibson will continue as an advisor, maintaining continuity with the founder's strategic input during the governance transition.

    Exhibit 99.1 verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (QRED 10-Q) is open in full — no account needed.

Partner

Trade RXRX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 22, 2026 12:11 AM